Search clinical trials for: Ambisome

Total 56 results

Drugs for Neglected Diseases
Novartis Pharmaceuticals

Recruiting

A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis

Primary Visceral Leishmaniasis

India
F2G Biotech GmbH
Iqvia Pty Ltd; Shionogi

Recruiting

Olorofim Aspergillus Infection Study (OASIS)

Invasive Aspergillosis

United States, Taiwan, Belgium, Spain, Italy, Turkey, New Zealand, China, Canada, Netherlands, Australia, Brazil, Singapore, Israel, France, Thailand, Germany, Japan, Korea, Republic of, United Kingdom
Makerere University
Gilead Sciences; University of Minnesota

Recruiting

Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia (ACACIA)

Cryptococcal Meningitis

Uganda
Poitiers University Hospital

Recruiting

Chronic Pulmonary Aspergillosis and Ambisome Aerosol With Itraconazole

Chronic Pulmonary Aspergillosis

France
Lundquist Institute for Biomedical Innovation at...
Novartis; Gilead Sciences; Astellas Pharma Inc

Completed

The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study

Mucormycosis

United States
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....

Completed

Bioequivalence of Amphotericin B Liposome for Injection

Bioequivalence

China
Fundacion para la Investigacion Biomedica del Hospital...

Completed

Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study) (NAIFI01)

Invasive Pulmonary Aspergillosis

Spain
Dongkook Pharmaceutical Co., Ltd.

Completed

Pharmacokinetics and Safety of AmBisome and DKF-5122

Invasive Fungal Infections | Neutropenic Fever

Korea, Republic of
Erasmus Medical Center
Gilead Sciences

Completed

PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome. (AzorMan)

Aspergillosis, Invasive Pulmonary

Netherlands
National Institute of Allergy and Infectious Diseases...

Completed

High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals

HIV Infections | Cryptococcal Meningitis

Kenya, Thailand, Uganda, United States, Peru, South Africa, Zimbabwe, India
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....

Completed

A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy Subjects

Bioequivalence

China
Radboud University Medical Center

Completed

Liposomal Amphotericin B (AmBisome) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ASPEN)

Morbid Obesity

Netherlands
Poitiers University Hospital

Completed

Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded). (NEBULAMB)

Allergic Bronchopulmonary Aspergillosis

France
Drugs for Neglected Diseases

Unknown

Short Course Regimens for Treatment of PKDL (Sudan)

PKDL - Post-Kala-Azar Dermal Leishmanioid

Sudan
Aurobindo Pharma Ltd
Axis Clinicals Limited

Completed

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

Visceral Leishmaniasis

Bangladesh, India
Drugs for Neglected Diseases
London School of Hygiene and Tropical Medicine; Institute of Tropical Medicine... and other collaborators

Completed

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

Visceral Leishmaniasis

Ethiopia
Astellas Pharma Inc

Completed

Liver Transplant European Study Into the Prevention of Fungal Infection (TENPIN)

Liver Transplantation | Mycoses

Belgium, France, Italy, Spain, Ireland, Germany, Portugal, Saudi Arabia, Austria, United Kingdom, Russian Federation, Hungary, Sweden, Romania
Singapore General Hospital
National University Hospital, Singapore

Completed

To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early

Aspergillosis

Singapore
Medecins Sans Frontieres, Netherlands

Completed

Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh

Post-kala-azar Dermal Leishmaniasis
Bill McGhee
Astellas Pharma Inc

Completed

Antifungal Locks to Treat Fungal-related Central Line Infections

Central Line Fungal Infections

United States
University of Brasilia
Ministry of Health, Brazil; Conselho Nacional de Desenvolvimento Científico... and other collaborators

Terminated

Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil (LVBrasil)

Visceral Leishmaniasis

Brazil
Drugs for Neglected Diseases
Gilead Sciences; Paladin Labs Inc.

Completed

Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa

Primary Visceral Leishmaniasis

Kenya, Sudan
Merck Sharp & Dohme LLC

Completed

MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)

Neutropenia | Fever
Drugs for Neglected Diseases
Addis Ababa University

Terminated

Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL

Visceral Leishmaniasis

Ethiopia, Sudan
Drugs for Neglected Diseases
International Centre for Diarrhoeal Disease Research, Bangladesh; Shaheed Surhawardy...

Completed

Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh

Visceral Leishmaniasis

Bangladesh
Gilead Sciences

Completed

COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis

Invasive Aspergillosis

France
Gilead Sciences

Completed

PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia

Leukemia

France
Gilead Sciences

Completed

Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia (AmBiGuard)

Invasive Fungal Disease

United Kingdom
Astellas Pharma Inc

Completed

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

Candidiasis

United States, Canada
Astellas Pharma Inc

Terminated

Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis

Aspergillosis

United States
Fundacion SEIMC-GESIDA
Pfizer

Completed

Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients (AVALTRA)

Fungal Infection | Liver Disease

Spain
Banaras Hindu University
Rajendra Memorial Research Institute of Medical Sciences

Unknown

Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis

Visceral Leishmaniasis

India
Hospital Universitário Professor Edgard Santos

Completed

Liposomal Amphotericin in Disseminated Leishmaniasis

Disseminated Leishmaniasis

Brazil
Taiwan Liposome Company

Completed

An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects

Normal Healthy Subjects
National Institute of Allergy and Infectious Diseases...

Withdrawn

SCH708980 With and Without AmBisome for Visceral Leishmaniasis

Effects of Immunotherapy | Leishmaniasis

India
Duke University
Pediatric Pharmacology Research Units Network

Completed

Antimicrobial PK in Infants With Suspected or Confirmed Infection

Infection

United States
M.D. Anderson Cancer Center

Completed

Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
University Health Network, Toronto

Suspended

Safety and Efficacy Study of Inhaled AmBisome for Prevention of Aspergillus Colonization in Lung Transplant Recipients

Lung Transplant Recipient

Canada
Banaras Hindu University
Rajendra Memorial Research Institute of Medical Sciences

Completed

Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar

Visceral Leishmaniasis

India
Bharat Serums and Vaccines Limited
Ministry of Science and Technology

Completed

To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar

Leishmaniasis, Visceral

India
Gilead Sciences

Terminated

Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics

Febrile Neutropenia

Greece
National Institute of Allergy and Infectious Diseases...

Completed

Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants

Candidiasis

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia

Neutropenia

United States
Gilead Sciences

Completed

PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation

Fungus Diseases

Italy
Drugs for Neglected Diseases

Completed

Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis

Visceral Leishmaniasis

India
PETHEMA Foundation

Completed

Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis (AMBINEB)

Acute Myeloid Leukemia | Allogeneic Haematopoietic Progenitor Cell Transplant

Spain
Banaras Hindu University

Completed

Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis

Visceral Leishmaniasis

India
Gilead Sciences

Completed

CRITIC - Treatment of Candidemia and Invasive Candidiasis (CRITIC)

Candidemia | Invasive Candidiasis

Italy
University of Pittsburgh
Astellas Pharma US, Inc.

Completed

Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study

Lung Transplantation | Fungal Infections

United States
Pfizer
Vicuron Pharmaceuticals

Completed

A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).

Aspergillosis

United States

Search clinical trials for: Ambisome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations